Fast neurotransmitter identity of MCH neurons: Do contents depend on context?
•Neurotransmitter switching is increasingly recognized as a form of neuroplasticity.•Factors like age, sex, and environment may shape neurotransmitter identity.•The neurotransmitter identity of MCH neurons is still a matter of debate.•Inconsistent experimental design and animal models may explain th...
Saved in:
Published in: | Frontiers in neuroendocrinology Vol. 70; p. 101069 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
01-07-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Neurotransmitter switching is increasingly recognized as a form of neuroplasticity.•Factors like age, sex, and environment may shape neurotransmitter identity.•The neurotransmitter identity of MCH neurons is still a matter of debate.•Inconsistent experimental design and animal models may explain the discrepant data.
Hypothalamic melanin-concentrating hormone (MCH) neurons participate in many fundamental neuroendocrine processes. While some of their effects can be attributed to MCH itself, others appear to depend on co-released neurotransmitters. Historically, the subject of fast neurotransmitter co-release from MCH neurons has been contentious, with data to support MCH neurons releasing GABA, glutamate, both, and neither. Rather than assuming a position in that debate, this review considers the evidence for all sides and presents an alternative explanation: neurochemical identity, including classical neurotransmitter content, is subject to change. With an emphasis on the variability of experimental details, we posit that MCH neurons may release GABA and/or glutamate at different points according to environmental and contextual factors. Through the lens of the MCH system, we offer evidence that the field of neuroendocrinology would benefit from a more nuanced and dynamic interpretation of neurotransmitter identity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Current affiliation: GSK Pharmaceutical Manufacturing. |
ISSN: | 0091-3022 1095-6808 1095-6808 |
DOI: | 10.1016/j.yfrne.2023.101069 |